2017
DOI: 10.1016/j.cmi.2017.03.021
|View full text |Cite
|
Sign up to set email alerts
|

Whole genome sequencing of Shigella sonnei through PulseNet Latin America and Caribbean: advancing global surveillance of foodborne illnesses

Abstract: ObjectivesShigella sonnei is a globally important diarrhoeal pathogen tracked through the surveillance network PulseNet Latin America and Caribbean (PNLA&C), which participates in PulseNet International. PNLA&C laboratories use common molecular techniques to track pathogens causing foodborne illness. We aimed to demonstrate the possibility and advantages of transitioning to whole genome sequencing (WGS) for surveillance within existing networks across a continent where S. sonnei is endemic.MethodsWe applied WG… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
41
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(45 citation statements)
references
References 31 publications
3
41
0
1
Order By: Relevance
“…As mentioned previously, there were differences in the types of AMR seen between the two lineages found in the collection; only Lineage III isolates carried resistance to quinolones and macrolides, the two drugs of major concern especially in the United States. This observation has been seen in previous literature, as Lineage III S. sonnei have been found to harbor more AMR genotypes when compared to other lineages (8, 9, 29, 31, 32). In regards to quinolone resistance, which has been a primary focus especially in international S. sonnei studies, Lineage III S. sonnei isolates appear to solely carry chromosomal mutations linked to quinolone resistance.…”
Section: Discussionsupporting
confidence: 86%
See 2 more Smart Citations
“…As mentioned previously, there were differences in the types of AMR seen between the two lineages found in the collection; only Lineage III isolates carried resistance to quinolones and macrolides, the two drugs of major concern especially in the United States. This observation has been seen in previous literature, as Lineage III S. sonnei have been found to harbor more AMR genotypes when compared to other lineages (8, 9, 29, 31, 32). In regards to quinolone resistance, which has been a primary focus especially in international S. sonnei studies, Lineage III S. sonnei isolates appear to solely carry chromosomal mutations linked to quinolone resistance.…”
Section: Discussionsupporting
confidence: 86%
“…Previous studies of S. sonnei that have investigated phylogenetic segmentation align with the original analysis performed by Holt et al; all S . sonnei appear to cluster into the Global Lineages (8, 9, 29, 31, 32). The original study, however, did not contain Shigella from the United States, so lineage characterization of isolates originating from the United States was not performed until Chung The et al examined a collection of quinolone-resistant S. sonnei which included a few isolates from the United States (32).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Phylogenetic trees based on core genome SNPs were constructed with Parsnp v.1.2 [55]. To include contextualization of the position of the isolates sequenced in this study relative to the main lineages of EIEC and S. sonnei and the phylogenetic groups (PG) of S. flexneri randomly selected genomes from each lineage or phylogenetic group were included in the phylogenetic tree [3,19,22,56,57]. Details of these representatives and their accession numbers are depicted in Additional file 5.…”
Section: Genome Sequencing and Data Preparationmentioning
confidence: 99%
“…Unlike other Shigella, S. sonnei exists as a single serotype and has a population structure encompassing five lineages, of which lineage III successfully disseminated globally from the 1970s onwards. A key event facilitating the success of this lineage was the acquisition of a multi-drug resistance (MDR) phenotype, which distinguishes this population 5,6 . Antimicrobials are important for Shigella treatment and disease control, and the World Health Organization (WHO) currently recommends ciprofloxacin (fluoroquinolone) as a first-line treatment, followed by pivmecillinam (beta-lactam), ceftriaxone (cephalosporin), and azithromycin (macrolide) as alternatives 7 .…”
Section: Introductionmentioning
confidence: 99%